Aqsens Health and Research Teams from Nanjing and Shanghai Replicate Large-Scale Prostate Cancer Cohort Measurements in China
Aqsens Health’s team traveled to Shanghai in early July to conduct prostate cancer analyses in collaboration with research teams from Nanjing and Shanghai. The goal of the trip was to analyze a large, well-designed urine sample cohort using the latest phage-biosensors and protocols, replicating insights gained in Finland. The Aqsens team also trained the Chinese research teams to continue the work independently after their return. This collaboration combines Finnish biotech innovation with China’s research talent, advanced capabilities, and strong interest in urine-based analysis.
AQ Lab beta testing completed and the platform is ready for commercial deployment
After a year of development and a few months of final beta testing, AQ Lab is ready to be deployed as a research and development platform for E-TRF and biosensor-based projects.
Professor Tambet Teesalu joins Aqsens Health’s scientific advisors as a Senior Advisor in biosensor technology
Aqsens Health is happy to share that our scientific advisory team will be strengthened with Professor Tambet Teesalu’s phage and biosensor expertise.
Aqsens Health and Tartu University teaming up to research the capabilities of different phages as biosensors in diagnostics
Aqsens Health is pleased to announce its collaboration with Professor Tambet Teesalu's esteemed research group at the Laboratory of Precision and Nanomedicine, University of Tartu in Estonia. Together, they will delve into extensive research to explore the capabilities of different phages as biosensors.
Tapping into the full potential of E-TRF and biosensors
Aqsens Health’s E-TRF method and its biochemical and chemical sensors are designed and developed to build a comprehensive view of the diseases at a low-cost, making large-scale screening a concrete possibility…